Lynx1 Capital Management LP - 31 Dec 2025 SCHEDULE 13G/A Report for C4 Therapeutics, Inc. Common Stock, $0.0001 par value per share (CCCC)

Filing Manager
Lynx1 Capital Management LP
Reporting Manager
Lynx1 Capital Management LP
Security
C4 Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
CCCC
Shares outstanding
97,234,699 shares
Disclosed Ownership
7,098,133 shares
Ownership
7.3%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 13:45:15 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Lynx1 Capital Management LP 7.3% 7,098,133 0 7,098,133 /s/ Weston Nichols By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Weston Nichols 7.3% 7,098,133 0 7,098,133 /s/ Weston Nichols Weston Nichols, Individually